A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The Johns Hopkins Department of Psychiatry is conducting a research study to examine the
effectiveness of riluzole in treating the depressed phase of bipolar disorder. This
outpatient treatment study of medication or placebo will last 9-12 weeks. The study includes
medical and psychiatric evaluations as well as time-limited medication treatment at no cost,
and you will be compensated for your participation.